Log in to save to my catalogue

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutate...

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutate...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_844359ba1f3942419f2d7778d0d8115c

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

About this item

Full title

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

Publisher

London: BioMed Central Ltd

Journal title

BMC cancer, 2022-07, Vol.22 (1), p.1-775, Article 775

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Many previous studies have demonstrated that minor-frequency pretreatment T790M mutation (preT790M) could be detected by ultrasensitive methods in a considerable number of treatment-naïve, epidermal growth factor receptor (EGFR)-mutated, non-small cell lung cancer (NSCLC) cases. However, the impact of preT790M in resected cases on progno...

Alternative Titles

Full title

Prognostic impact of pretreatment T790M mutation on outcomes for patients with resected, EGFR-mutated, non-small cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_844359ba1f3942419f2d7778d0d8115c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_844359ba1f3942419f2d7778d0d8115c

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-022-09869-7

How to access this item